|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Syphilis is a sexually transmitted disease (STD), caused by Treponema pallidum. It not only has significant implications on public health but also facilitates the acquisition of other STDs such as HIV infection as well as complicates pregnancy related outcomes. Maternal syphilis is associated with stillbirths and spontaneous abortions in number of cases. Diagnosis of syphilis is dependent on antibody detection by non treponemal/ cardiolipin (screening test) and treponemal tests (confirmatory tests). Material and Methods: A total of 28,407 serum samples obtained from patients of various departments from January 2011 to December 2015. All the serum samples were screened by VDRL testing and confirmation was done by TPHA test. Results: Seroprevalence of syphilis in this study was 0.68%. Year-wise prevalence was 0.87% in 2011, 0.71% in 2012, 0.75% in 2013, 0.45% in 2014 and 0.67% in 2015. Seroprevalence of patients attending the skin and veneral disease clinic, obstetrics and gynaecology clinic and other departments were 3.27%, 0.35% and 2.23% respectively. Maximum prevalence was found in the sexually active age group i.e., 21-33 years. Conclusion: Various studies in India have shown similar rates of seroprevalence in the non high risk groups. A similar study in our institute done in the previous 5 consecutive years had shown higher rates of seroprevalence. The decreasing trend could be attributable to improved programs for prevention and management of STDs as well as availability of treatment in STD clinics. It is recommended to screen ANC cases for syphilis antibodies for early detection and prevention of complications.